![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_801c14f154b84be98d096d7e02cbd51f.svg) | Unii-1fgz6L9SF2 | Ki | 24.55 [1], 165.96 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e8bf2413bcad55afeb4d86362584a544.svg) | (4S)-6-[2-[(2R)-2-[(3,5-Dimethylphenyl)methyl]piperidin-1-yl]-2-oxoethyl]-4-(2H-indazol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one | Ki | 28.84 [1], 213.8 [2], 912.01 [3] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_eeccb0399c50d21f228b3ba98efa3a57.svg) | Tert-butyl N-[(2S)-1-[[(4aS,5R)-2-naphthalen-1-yl-1,3-dioxo-4,4a,5,6,7,8-hexahydropyrido[1,2-c]pyrimidin-5-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate | IC50 | 8.9 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_1f3442327791256706efc54ac139be55.svg) | Tert-butyl N-[(2S)-1-[[(4aS,5R)-1,3-dioxo-2-phenyl-4,4a,5,6,7,8-hexahydropyrido[1,2-c]pyrimidin-5-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate | IC50 | 35.2 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_b5f4ce5fdb4661063a0913c820117195.svg) | Tert-butyl N-[(2S)-1-[[(4aS,5R)-2-benzyl-3-oxo-1-sulfanyl-4,4a,5,6,7,8-hexahydro-1H-pyrido[1,2-c]pyrimidin-5-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate | IC50 | 27.5 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_3c7efb373cdf7a2af9541e4e8353b3b8.svg) | Sincalide | Ki | 0.28 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_71f4d08af1c8dcbf1fddf9ff6b16b69e.svg) | Devazepide | IC50 | 0.08 [1], 0.49 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_71f4d08af1c8dcbf1fddf9ff6b16b69e.svg) | Devazepide | Ki | 0.02 [1], 1.82 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_41b4e85d94966ef68467f8a4dbf0c0ea.svg) | 2-[2,4-Dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide | IC50 | 50.12 [1], 54.95 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_41b4e85d94966ef68467f8a4dbf0c0ea.svg) | 2-[2,4-Dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide | Ki | 50.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_ee2f2631bbc4e05f2c38a207f35f9421.svg) | Netazepide | Ki | 28.84 [1], 30.2 [2], 31.62 [3] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_c859dafa182e28225bdea507020e5c57.svg) | Gski181771X | IC50 | 105.0 [1], 128.0 [2], 131.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_a73bc16d38f67d7db69fdeb57eaa7c53.svg) | 2-(2-(1H-Indole-2-carboxamido)benzamido)-3-phenylpropanoic acid | IC50 | 197.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_a73bc16d38f67d7db69fdeb57eaa7c53.svg) | 2-(2-(1H-Indole-2-carboxamido)benzamido)-3-phenylpropanoic acid | Ki | 31.62 [1], 59.8 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_0df6ad93aa1161b9ea47b408a183e233.svg) | 3-[[2-[5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]benzoic acid | Ki | 10000.0 [1], 11220.18 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e8eea9c7c1aa9a52083f5fb0e2059896.svg) | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea | IC50 | 158.49 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e8eea9c7c1aa9a52083f5fb0e2059896.svg) | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea | Ki | 173.78 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_9c01b433fbab0d1d5bd8cfb60532b07f.svg) | Asperlicin | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_d4dd0fcdb14ccf7770332d7287d8d477.svg) | CID 5311148 | IC50 | 22.91 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_b64d019e0fef474a7d5ca4a6c52dd45c.svg) | Tert-butyl N-[(2S)-1-[[(4aS,5S)-2-benzyl-1,3-dioxo-4,4a,5,6,7,8-hexahydropyrido[1,2-c]pyrimidin-5-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate | IC50 | 6850.0 [1], 20860.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_34797e1da86428b5a79244605df8bc89.svg) | N-[4-Chloro-2-(piperidin-1-ylcarbonyl)phenyl]-2,1,3-benzothiadiazole-4-sulfonamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_dc35e6afc97b85abbd773abaae6196b3.svg) | 4-[4-Iodo-2-[(5-quinoxalinylsulfonyl)amino]benzoyl]-morpholine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_ae13f8ca6745ab44e3429a176c41c479.svg) | 1-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-bromobenzoyl]-piperidine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_242d1b6c20d89536c72cb6f08732c1dc.svg) | 2-[3-Methyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide | IC50 | 75.86 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_95a47d0c811082132138d55b78ec5b02.svg) | N-(4-Methoxyphenyl)-2-[3-[(1-methylindazol-3-yl)methyl]-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-propan-2-ylacetamide | IC50 | 42.66 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_eb34dbc6b9927f00adc4bdc162dedb46.svg) | 2-[3-[(1-Benzylindazol-3-yl)methyl]-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 309.03 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_4e82c741984d754349a98bd16d0b923e.svg) | 2-[3-(1H-Indol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 10.81 [1], 10.96 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e81b16637b5f71da095d1a1ba7a6c051.svg) | 2-[3-(2H-Indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide | IC50 | 87.1 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_86531bd2497a311b4bc9404801494c0d.svg) | 2-[2,4-Dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide | IC50 | 154.88 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_86531bd2497a311b4bc9404801494c0d.svg) | 2-[2,4-Dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide | Ki | 158.49 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_319c976c4fb00bb434c791ba44ebee71.svg) | 2-[3-(2H-Indazol-3-ylmethyl)-3-methyl-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 13.18 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_357474844d4a8527fdf648028d6e34e7.svg) | 2-[3-(1H-Indol-3-ylmethyl)-3-methyl-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 8.32 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_988a69621a96317889fdbc927ba47688.svg) | 1-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-chlorobenzoyl]-piperidine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_3d9cec924ec69e497780da69abc66a7b.svg) | Tyr-D-Ala-Gly-D-Trp-NMeNle-Asp-Phe-NH2 | Ki | 32.0 [1], 320.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_57a505ec2a2a4af95b2d210a27f93c6d.svg) | 1-[2-[(2,1,3-Benzooxadiazol-4-ylsulfonyl)amino]-4-chlorobenzoyl]-piperidine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e173a5ea255d4367cc8ec56cecadb017.svg) | N-(5-Bromo-2-(piperidine-1-carbonyl)phenyl)isoquinoline-5-sulfonamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_a92cf77a34fe08d244bedc815aa31d99.svg) | 2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-chloro-N-(phenylmethyl)-benzamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e8b0108e0bdf8f8e42febf1f662c345f.svg) | N-(5-Chloro-2-(piperidine-1-carbonyl)phenyl)quinoline-8-sulfonamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_1b808c1764ddebf628c40d731cfc739c.svg) | 1-[4-Bromo-2-[(quinolin-5-ylsulfonyl)amino]-benzoyl]-piperidine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_8dea288373a6152a2c84b75446003e20.svg) | 1-[4-Bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzoyl]-piperidine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_d36ff4bd6e96c3d1816399a59e9cea7f.svg) | 3-[4-[1-(3-Ethoxyphenyl)-2-(4-methylphenyl)imidazole-4-carbonyl]piperazin-1-yl]naphthalene-1-carboxylic acid | IC50 | 0.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_45f75acb8b68616d58334d1b0a3e1e79.svg) | 3-[4-[1-(3-Ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)imidazole-4-carbonyl]piperazin-1-yl]naphthalene-1-carboxylic acid | IC50 | 0.04 [1], 0.06 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_55728208af8857916f651caf827c75cd.svg) | [1-(3-Ethoxyphenyl)-2-(4-methylphenyl)imidazol-4-yl]-(4-quinolin-3-ylpiperazin-1-yl)methanone | IC50 | 0.45 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_563b732303c082d704cfd2360b191f5a.svg) | 3-[[2,4-Dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid | IC50 | 125.89 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_563b732303c082d704cfd2360b191f5a.svg) | 3-[[2,4-Dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid | Ki | 125.89 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_1e7b3f923cd4b434d93d6c5ba5e3d807.svg) | 1-[(3S)-5-Cyclohexyl-2,4-dioxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)-1,5-benzodiazepin-3-yl]-3-(4-fluorophenyl)urea | Ki | 79.43 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_c70f5b79af37726016ec15cea0b55e94.svg) | Propranolol | IC50 | 5011.87 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_71acea9a6dfc0e4dac7865946b73384c.svg) | Paclitaxel | Ki | 2276.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_67fb1b66ccd5e5496742007548f61409.svg) | Loxiglumide | IC50 | 195.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_21b0954e948f1fac3d79a34d33c554d6.svg) | CID 108187 | IC50 | 1047.13 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_613bd559e314252ec76ed0cdf79b77e9.svg) | 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_51bdbb7604c84c62430d5887a929fd9b.svg) | Lintitript | IC50 | 0.56 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e39e3bc989cee0b1a0a409acf38c8621.svg) | Cipargamin | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_0aba48633a4ed42abcb42aa90c895c5a.svg) | CID 121964 | IC50 | 1900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_48438bcceb431b41622ad25f9534185d.svg) | Devazepida | Ki | 10.4 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_a186212bacffc4f00dfe37c241f56f83.svg) | (3S)-3-Amino-4-[[(2S)-1-[[(2R)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-methylamino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid | Ki | 3200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_0d0f840ca6219f3447478aa8f365710c.svg) | 4-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]benzoyl]-morpholine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_0fb2cb0d3042c1680f77b1bdd409f3fc.svg) | 3-{[5-(Adamantan-1-yloxymethyl)-2-cyclohexyl-1H-imidazole-4-carbonyl]-amino}-benzoic acid | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_8d6723bf5a46483beb1e9bf27bad3459.svg) | (3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]-methylamino]hexanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid | Ki | 1080.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_91760fe48fa0a6355f9455ec96a5d008.svg) | (3S)-3-[[(2S)-2-[[(2S)-2-Acetamido-3-(1H-indol-3-yl)propanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-methylamino]-4-oxobutanoic acid | IC50 | 19.95 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_744d1e6fe104c45967adf6ad3e67214d.svg) | 2-[2,4-Dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 79.43 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_ccbcc3c221fc70a5d3c57f3e4f744342.svg) | Tyr-D-Phe-Gly-D-Trp-NMeNle-Asp-Phe-NH2 | Ki | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_7b4d7a237ae1d8e61abbfb1475cb1059.svg) | Tyr-Gly-Gly-Trp-NMeNle-Asp-Phe-NH2 | Ki | 870.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_1c5972edf7167f068e1670e10876d37f.svg) | 3-Phenyl-2-[[2-[[(E)-3-phenylprop-2-enoyl]amino]benzoyl]amino]propanoic acid | IC50 | 4000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_230afff0a01f7d70042640f7d82fe383.svg) | 2-(1-(3,4-Difluorophenylsulfonyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid | IC50 | 8100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_aceabd5c904dc746ada6fca37e749b98.svg) | 2-[5-Cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]acetamide | Ki | 467.74 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_f5bc4adabe3e298b52c99fb54d451040.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-methylamino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[2-[[(2S)-2-[3-(4-sulfooxyphenyl)propanoylamino]hexanoyl]amino]acetyl]amino]propanoyl]amino]hexanoyl]amino]-4-oxobutanoic acid | IC50 | 0.99 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_e6570ff658689ced0aa034ed4b395a20.svg) | 1-[2-[(2,1,3-Benzothiadiazol-5-ylsulfonyl)amino]-4-bromobenzoyl]-piperidine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_b00d19da610fa1fb84284b2be1378f12.svg) | 2-[[2-(1H-Indole-2-carbonylamino)benzoyl]amino]-4-phenylbutanoic acid | Ki | 3.9 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_be4a197ea4e448059f5b349be9a356d8.svg) | 2-[[2-(1H-Indole-2-carbonylamino)benzoyl]amino]propanoic acid | IC50 | 2800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_6097f8a87bf15eb97a543108c6ce6c87.svg) | (2S)-2-[[2-(2,1,3-Benzothiadiazol-4-ylsulfonylamino)-4-chlorobenzoyl]amino]-3-(3,4-dichlorophenyl)propanoic acid | Ki | 251.19 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_7279d25e3e0cf71f16896d6ab4cc6560.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[2-[[(2S)-2-[3-(4-sulfooxyphenyl)propanoylamino]hexanoyl]amino]acetyl]amino]propanoyl]amino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 0.5 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_a930b6ba91a01e6840e91d3f44a0fc53.svg) | 4-[[(2R)-1-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexan-2-yl]amino]-4-oxobutanoic acid | IC50 | 12.02 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_8463f69e7fb019f72a106face3b69080.svg) | 4-[[(2R)-1-[[(2S)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexan-2-yl]amino]-4-oxobutanoic acid | IC50 | 229.09 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_014e9ac1af64f9e0dddfe392ea9445a6.svg) | 3-[1-(4-Methoxyphenyl)-5-(4-methylphenyl)pyrazol-3-yl]-2-(4-methylphenyl)propanoic acid | Ki | 25.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_6031654be12ca9214a10f90ef0983b44.svg) | 2-(3-Chlorophenyl)-3-[1-(4-methoxyphenyl)-5-(4-methylphenyl)pyrazol-3-yl]propanoic acid | Ki | 25.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_73a65446607390049a8d366c2df4787f.svg) | 4-[[(2S)-2-[[(2S)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexyl]amino]-4-oxobutanoic acid | IC50 | 724.44 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_908de9e686aa39e57b7333c4498186e3.svg) | 2-(4-Methoxyphenyl)-3-[1-(4-methoxyphenyl)-5-(4-methylphenyl)pyrazol-3-yl]propanoic acid | Ki | 25.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_4a51bc8efe2a71e0b650926db6007f14.svg) | 2-(3-Methoxyphenyl)-3-[1-(4-methoxyphenyl)-5-(4-methylphenyl)pyrazol-3-yl]propanoic acid | Ki | 25.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_b147accf38e3222677d65c394894b88a.svg) | 2-[2,4-Dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-hydroxyphenyl)-N-propan-2-ylacetamide | IC50 | 39.81 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_352acda34bd49e5d243b7d833521c607.svg) | 2-(4-Chlorophenyl)-3-[1-(4-methoxyphenyl)-5-(4-methylphenyl)pyrazol-3-yl]propanoic acid | Ki | 25.12 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_3880323deefdacedb2c929bc7e994c59.svg) | [[3-(2-Naphthyl)-2-methyl-2-[[(2-adamantyloxy)carbonyl]amino]propionyl]phenethylamino]acetic acid | Ki | 3006.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_79b2a4f049c571421ea9545d5fa1a984.svg) | N-[2,4-Dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 15.85 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_945696852c62dc9de71cf27f00771435.svg) | 2-[3-Methyl-2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide | IC50 | 1318.26 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_643eeeb7bacf1401cac8dd088cb40243.svg) | 2-[3-(2H-Indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(2-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 1584.89 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_0aa1ccb1625a8125a9758e41754ffc02.svg) | N-(4-Fluorophenyl)-2-[3-(2H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-propan-2-ylacetamide | IC50 | 138.04 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_9ffbe062a767c1c10abd4dec9d748680.svg) | 2-[3-Ethyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide | IC50 | 36.31 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_a5ac37ec7cb33d761bea8f94e42a14e0.svg) | 2-[3-(1H-Indol-3-ylmethyl)-3-methoxy-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 13.8 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_f1ae672b3646673670c2814be51b40b4.svg) | 2-[3-Benzyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide | IC50 | 389.05 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_9fafd8459e18cbbfbd6a3cbb46020c1a.svg) | 2-[3-[(4-Fluoro-2H-indazol-3-yl)methyl]-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 17.38 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_3c1bbec5bfbb1706a42b2ed2302afccc.svg) | 2-[3-[(7-Fluoro-2H-indazol-3-yl)methyl]-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 20.89 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_4295bfac65f792a9a6da18301bc87bcc.svg) | N-Cyclopropyl-2-[3-(2H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-phenylacetamide | IC50 | 524.81 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_0587ebc5f50310df68f6a4fd08b27099.svg) | N-Tert-butyl-2-[3-(2H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-phenylacetamide | IC50 | 891.25 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_fa3c0fcb390caa5127889da38e8b5eb1.svg) | 2-[3-(2H-Indazol-3-ylmethyl)-3-methoxy-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 14.45 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-a-receptor_68962211728069dcad27a135d0703bdb.svg) | 2-[3-[(6-Fluoro-2H-indazol-3-yl)methyl]-2,4-dioxo-5-phenyl-1,5-benzodiazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide | IC50 | 29.51 [1] |